טוען...
Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one
Peptide(540–548), peptide(611–626), peptide(672–686) and peptide(766–780), which are derived from human telomerase, constitute the immunogenic component of the GX301 cancer vaccine. The relative immunogenicity of these peptides is unknown, thus it is unsure whether their combined use offers real adv...
שמור ב:
הוצא לאור ב: | Hum Vaccin Immunother |
---|---|
Main Authors: | , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Taylor & Francis
2015
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514186/ https://ncbi.nlm.nih.gov/pubmed/25714118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1012032 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|